nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP1A2—Carmustine—lymphatic system cancer	0.14	0.239	CbGbCtD
Pentamidine—CYP3A5—Teniposide—lymphatic system cancer	0.127	0.215	CbGbCtD
Pentamidine—CYP2C19—Teniposide—lymphatic system cancer	0.102	0.174	CbGbCtD
Pentamidine—CYP3A5—Vincristine—lymphatic system cancer	0.0609	0.104	CbGbCtD
Pentamidine—CYP3A4—Cytarabine—lymphatic system cancer	0.0501	0.0853	CbGbCtD
Pentamidine—CYP3A4—Teniposide—lymphatic system cancer	0.0494	0.084	CbGbCtD
Pentamidine—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0345	0.0588	CbGbCtD
Pentamidine—CYP3A4—Vincristine—lymphatic system cancer	0.0238	0.0404	CbGbCtD
Pentamidine—Abdominal pain—Teniposide—lymphatic system cancer	0.000741	0.0018	CcSEcCtD
Pentamidine—Body temperature increased—Teniposide—lymphatic system cancer	0.000741	0.0018	CcSEcCtD
Pentamidine—Erythema—Bleomycin—lymphatic system cancer	0.00074	0.00179	CcSEcCtD
Pentamidine—Paraesthesia—Fludarabine—lymphatic system cancer	0.000739	0.00179	CcSEcCtD
Pentamidine—Hallucination—Carmustine—lymphatic system cancer	0.000738	0.00179	CcSEcCtD
Pentamidine—Hypoaesthesia—Carmustine—lymphatic system cancer	0.000738	0.00179	CcSEcCtD
Pentamidine—Dyspnoea—Fludarabine—lymphatic system cancer	0.000734	0.00178	CcSEcCtD
Pentamidine—Haematuria—Mitoxantrone—lymphatic system cancer	0.000733	0.00178	CcSEcCtD
Pentamidine—Oedema peripheral—Carmustine—lymphatic system cancer	0.000731	0.00177	CcSEcCtD
Pentamidine—Dyspepsia—Fludarabine—lymphatic system cancer	0.000725	0.00176	CcSEcCtD
Pentamidine—Sinusitis—Mitoxantrone—lymphatic system cancer	0.000721	0.00175	CcSEcCtD
Pentamidine—Decreased appetite—Fludarabine—lymphatic system cancer	0.000716	0.00174	CcSEcCtD
Pentamidine—Fatigue—Fludarabine—lymphatic system cancer	0.00071	0.00172	CcSEcCtD
Pentamidine—Hallucination—Vincristine—lymphatic system cancer	0.000705	0.00171	CcSEcCtD
Pentamidine—Hypoaesthesia—Vincristine—lymphatic system cancer	0.000705	0.00171	CcSEcCtD
Pentamidine—Constipation—Fludarabine—lymphatic system cancer	0.000704	0.00171	CcSEcCtD
Pentamidine—Pain—Fludarabine—lymphatic system cancer	0.000704	0.00171	CcSEcCtD
Pentamidine—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000702	0.0017	CcSEcCtD
Pentamidine—Vasculitis—Methotrexate—lymphatic system cancer	0.000701	0.0017	CcSEcCtD
Pentamidine—Rhinitis—Mitoxantrone—lymphatic system cancer	0.000691	0.00168	CcSEcCtD
Pentamidine—Hypersensitivity—Teniposide—lymphatic system cancer	0.00069	0.00167	CcSEcCtD
Pentamidine—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00069	0.00167	CcSEcCtD
Pentamidine—Flushing—Carmustine—lymphatic system cancer	0.000688	0.00167	CcSEcCtD
Pentamidine—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.000685	0.00166	CcSEcCtD
Pentamidine—Anaemia—Bleomycin—lymphatic system cancer	0.000684	0.00166	CcSEcCtD
Pentamidine—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000679	0.00165	CcSEcCtD
Pentamidine—Asthenia—Teniposide—lymphatic system cancer	0.000672	0.00163	CcSEcCtD
Pentamidine—Melaena—Methotrexate—lymphatic system cancer	0.000668	0.00162	CcSEcCtD
Pentamidine—Pruritus—Teniposide—lymphatic system cancer	0.000663	0.00161	CcSEcCtD
Pentamidine—Arrhythmia—Carmustine—lymphatic system cancer	0.000663	0.00161	CcSEcCtD
Pentamidine—Leukopenia—Bleomycin—lymphatic system cancer	0.000662	0.00161	CcSEcCtD
Pentamidine—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000653	0.00158	CcSEcCtD
Pentamidine—Body temperature increased—Fludarabine—lymphatic system cancer	0.000651	0.00158	CcSEcCtD
Pentamidine—Erythema—Carmustine—lymphatic system cancer	0.000646	0.00157	CcSEcCtD
Pentamidine—Cough—Bleomycin—lymphatic system cancer	0.000646	0.00157	CcSEcCtD
Pentamidine—Diarrhoea—Teniposide—lymphatic system cancer	0.000641	0.00156	CcSEcCtD
Pentamidine—Chest pain—Bleomycin—lymphatic system cancer	0.00063	0.00153	CcSEcCtD
Pentamidine—Myalgia—Bleomycin—lymphatic system cancer	0.00063	0.00153	CcSEcCtD
Pentamidine—Discomfort—Bleomycin—lymphatic system cancer	0.000622	0.00151	CcSEcCtD
Pentamidine—Chills—Mitoxantrone—lymphatic system cancer	0.000619	0.0015	CcSEcCtD
Pentamidine—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000619	0.0015	CcSEcCtD
Pentamidine—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000616	0.00149	CcSEcCtD
Pentamidine—Confusional state—Bleomycin—lymphatic system cancer	0.000609	0.00148	CcSEcCtD
Pentamidine—Vision blurred—Carmustine—lymphatic system cancer	0.000609	0.00148	CcSEcCtD
Pentamidine—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000607	0.00147	CcSEcCtD
Pentamidine—Tremor—Carmustine—lymphatic system cancer	0.000605	0.00147	CcSEcCtD
Pentamidine—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.000604	0.00146	CcSEcCtD
Pentamidine—Erythema—Mitoxantrone—lymphatic system cancer	0.0006	0.00146	CcSEcCtD
Pentamidine—Infection—Bleomycin—lymphatic system cancer	0.0006	0.00146	CcSEcCtD
Pentamidine—Anaemia—Carmustine—lymphatic system cancer	0.000597	0.00145	CcSEcCtD
Pentamidine—Vomiting—Teniposide—lymphatic system cancer	0.000596	0.00145	CcSEcCtD
Pentamidine—Sepsis—Methotrexate—lymphatic system cancer	0.000594	0.00144	CcSEcCtD
Pentamidine—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000591	0.00143	CcSEcCtD
Pentamidine—Asthenia—Fludarabine—lymphatic system cancer	0.000591	0.00143	CcSEcCtD
Pentamidine—Rash—Teniposide—lymphatic system cancer	0.000591	0.00143	CcSEcCtD
Pentamidine—Dermatitis—Teniposide—lymphatic system cancer	0.00059	0.00143	CcSEcCtD
Pentamidine—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000588	0.00143	CcSEcCtD
Pentamidine—Headache—Teniposide—lymphatic system cancer	0.000587	0.00142	CcSEcCtD
Pentamidine—Pruritus—Fludarabine—lymphatic system cancer	0.000583	0.00141	CcSEcCtD
Pentamidine—Leukopenia—Carmustine—lymphatic system cancer	0.000578	0.0014	CcSEcCtD
Pentamidine—Anorexia—Bleomycin—lymphatic system cancer	0.000576	0.0014	CcSEcCtD
Pentamidine—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000571	0.00139	CcSEcCtD
Pentamidine—Anaemia—Vincristine—lymphatic system cancer	0.00057	0.00138	CcSEcCtD
Pentamidine—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000566	0.00137	CcSEcCtD
Pentamidine—Hypotension—Bleomycin—lymphatic system cancer	0.000564	0.00137	CcSEcCtD
Pentamidine—Diarrhoea—Fludarabine—lymphatic system cancer	0.000563	0.00137	CcSEcCtD
Pentamidine—Convulsion—Carmustine—lymphatic system cancer	0.00056	0.00136	CcSEcCtD
Pentamidine—Hypertension—Carmustine—lymphatic system cancer	0.000558	0.00135	CcSEcCtD
Pentamidine—Nausea—Teniposide—lymphatic system cancer	0.000557	0.00135	CcSEcCtD
Pentamidine—Anaemia—Mitoxantrone—lymphatic system cancer	0.000555	0.00135	CcSEcCtD
Pentamidine—Vertigo—Vincristine—lymphatic system cancer	0.000554	0.00134	CcSEcCtD
Pentamidine—Leukopenia—Vincristine—lymphatic system cancer	0.000552	0.00134	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00055	0.00133	CcSEcCtD
Pentamidine—Chest pain—Carmustine—lymphatic system cancer	0.00055	0.00133	CcSEcCtD
Pentamidine—Myalgia—Carmustine—lymphatic system cancer	0.00055	0.00133	CcSEcCtD
Pentamidine—Anxiety—Carmustine—lymphatic system cancer	0.000548	0.00133	CcSEcCtD
Pentamidine—Paraesthesia—Bleomycin—lymphatic system cancer	0.000542	0.00132	CcSEcCtD
Pentamidine—Dyspnoea—Bleomycin—lymphatic system cancer	0.000538	0.00131	CcSEcCtD
Pentamidine—Renal failure acute—Methotrexate—lymphatic system cancer	0.000538	0.00131	CcSEcCtD
Pentamidine—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000537	0.0013	CcSEcCtD
Pentamidine—Convulsion—Vincristine—lymphatic system cancer	0.000534	0.0013	CcSEcCtD
Pentamidine—Hypertension—Vincristine—lymphatic system cancer	0.000532	0.00129	CcSEcCtD
Pentamidine—Confusional state—Carmustine—lymphatic system cancer	0.000531	0.00129	CcSEcCtD
Pentamidine—Decreased appetite—Bleomycin—lymphatic system cancer	0.000525	0.00127	CcSEcCtD
Pentamidine—Myalgia—Vincristine—lymphatic system cancer	0.000525	0.00127	CcSEcCtD
Pentamidine—Cough—Mitoxantrone—lymphatic system cancer	0.000524	0.00127	CcSEcCtD
Pentamidine—Infection—Carmustine—lymphatic system cancer	0.000524	0.00127	CcSEcCtD
Pentamidine—Vomiting—Fludarabine—lymphatic system cancer	0.000524	0.00127	CcSEcCtD
Pentamidine—Convulsion—Mitoxantrone—lymphatic system cancer	0.00052	0.00126	CcSEcCtD
Pentamidine—Rash—Fludarabine—lymphatic system cancer	0.000519	0.00126	CcSEcCtD
Pentamidine—Dermatitis—Fludarabine—lymphatic system cancer	0.000519	0.00126	CcSEcCtD
Pentamidine—Hypertension—Mitoxantrone—lymphatic system cancer	0.000518	0.00126	CcSEcCtD
Pentamidine—Pain—Bleomycin—lymphatic system cancer	0.000516	0.00125	CcSEcCtD
Pentamidine—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000516	0.00125	CcSEcCtD
Pentamidine—Headache—Fludarabine—lymphatic system cancer	0.000516	0.00125	CcSEcCtD
Pentamidine—Tachycardia—Carmustine—lymphatic system cancer	0.000514	0.00125	CcSEcCtD
Pentamidine—Chest pain—Mitoxantrone—lymphatic system cancer	0.000511	0.00124	CcSEcCtD
Pentamidine—Myalgia—Mitoxantrone—lymphatic system cancer	0.000511	0.00124	CcSEcCtD
Pentamidine—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000511	0.00124	CcSEcCtD
Pentamidine—Anxiety—Mitoxantrone—lymphatic system cancer	0.000509	0.00124	CcSEcCtD
Pentamidine—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000507	0.00123	CcSEcCtD
Pentamidine—Lethargy—Methotrexate—lymphatic system cancer	0.000507	0.00123	CcSEcCtD
Pentamidine—Discomfort—Mitoxantrone—lymphatic system cancer	0.000505	0.00123	CcSEcCtD
Pentamidine—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000503	0.00122	CcSEcCtD
Pentamidine—Anorexia—Carmustine—lymphatic system cancer	0.000502	0.00122	CcSEcCtD
Pentamidine—Infection—Vincristine—lymphatic system cancer	0.0005	0.00121	CcSEcCtD
Pentamidine—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000498	0.00121	CcSEcCtD
Pentamidine—Confusional state—Mitoxantrone—lymphatic system cancer	0.000494	0.0012	CcSEcCtD
Pentamidine—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000493	0.0012	CcSEcCtD
Pentamidine—Hypotension—Carmustine—lymphatic system cancer	0.000492	0.00119	CcSEcCtD
Pentamidine—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00049	0.00119	CcSEcCtD
Pentamidine—Nausea—Fludarabine—lymphatic system cancer	0.000489	0.00119	CcSEcCtD
Pentamidine—Infection—Mitoxantrone—lymphatic system cancer	0.000487	0.00118	CcSEcCtD
Pentamidine—Shock—Mitoxantrone—lymphatic system cancer	0.000482	0.00117	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00048	0.00116	CcSEcCtD
Pentamidine—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00048	0.00116	CcSEcCtD
Pentamidine—Urticaria—Bleomycin—lymphatic system cancer	0.00048	0.00116	CcSEcCtD
Pentamidine—Anorexia—Vincristine—lymphatic system cancer	0.00048	0.00116	CcSEcCtD
Pentamidine—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000478	0.00116	CcSEcCtD
Pentamidine—Body temperature increased—Bleomycin—lymphatic system cancer	0.000477	0.00116	CcSEcCtD
Pentamidine—Insomnia—Carmustine—lymphatic system cancer	0.000477	0.00116	CcSEcCtD
Pentamidine—Paraesthesia—Carmustine—lymphatic system cancer	0.000473	0.00115	CcSEcCtD
Pentamidine—Mood swings—Methotrexate—lymphatic system cancer	0.000471	0.00114	CcSEcCtD
Pentamidine—Hypotension—Vincristine—lymphatic system cancer	0.00047	0.00114	CcSEcCtD
Pentamidine—Dyspnoea—Carmustine—lymphatic system cancer	0.00047	0.00114	CcSEcCtD
Pentamidine—Somnolence—Carmustine—lymphatic system cancer	0.000469	0.00114	CcSEcCtD
Pentamidine—Anorexia—Mitoxantrone—lymphatic system cancer	0.000467	0.00113	CcSEcCtD
Pentamidine—Liver function test abnormal—Methotrexate—lymphatic system cancer	0.000459	0.00111	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000458	0.00111	CcSEcCtD
Pentamidine—Decreased appetite—Carmustine—lymphatic system cancer	0.000458	0.00111	CcSEcCtD
Pentamidine—Hypotension—Mitoxantrone—lymphatic system cancer	0.000458	0.00111	CcSEcCtD
Pentamidine—Insomnia—Vincristine—lymphatic system cancer	0.000455	0.0011	CcSEcCtD
Pentamidine—Paraesthesia—Vincristine—lymphatic system cancer	0.000452	0.0011	CcSEcCtD
Pentamidine—Pain—Carmustine—lymphatic system cancer	0.000451	0.00109	CcSEcCtD
Pentamidine—Constipation—Carmustine—lymphatic system cancer	0.000451	0.00109	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000446	0.00108	CcSEcCtD
Pentamidine—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000445	0.00108	CcSEcCtD
Pentamidine—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00044	0.00107	CcSEcCtD
Pentamidine—Decreased appetite—Vincristine—lymphatic system cancer	0.000437	0.00106	CcSEcCtD
Pentamidine—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000437	0.00106	CcSEcCtD
Pentamidine—Somnolence—Mitoxantrone—lymphatic system cancer	0.000436	0.00106	CcSEcCtD
Pentamidine—Feeling abnormal—Carmustine—lymphatic system cancer	0.000434	0.00105	CcSEcCtD
Pentamidine—Fatigue—Vincristine—lymphatic system cancer	0.000434	0.00105	CcSEcCtD
Pentamidine—Asthenia—Bleomycin—lymphatic system cancer	0.000433	0.00105	CcSEcCtD
Pentamidine—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000431	0.00105	CcSEcCtD
Pentamidine—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000431	0.00105	CcSEcCtD
Pentamidine—Pain—Vincristine—lymphatic system cancer	0.00043	0.00104	CcSEcCtD
Pentamidine—Constipation—Vincristine—lymphatic system cancer	0.00043	0.00104	CcSEcCtD
Pentamidine—Asthma—Methotrexate—lymphatic system cancer	0.000429	0.00104	CcSEcCtD
Pentamidine—Pruritus—Bleomycin—lymphatic system cancer	0.000427	0.00104	CcSEcCtD
Pentamidine—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000426	0.00103	CcSEcCtD
Pentamidine—Eosinophilia—Methotrexate—lymphatic system cancer	0.000425	0.00103	CcSEcCtD
Pentamidine—Fatigue—Mitoxantrone—lymphatic system cancer	0.000422	0.00102	CcSEcCtD
Pentamidine—Pancreatitis—Methotrexate—lymphatic system cancer	0.000421	0.00102	CcSEcCtD
Pentamidine—Constipation—Mitoxantrone—lymphatic system cancer	0.000419	0.00102	CcSEcCtD
Pentamidine—Pain—Mitoxantrone—lymphatic system cancer	0.000419	0.00102	CcSEcCtD
Pentamidine—Abdominal pain—Carmustine—lymphatic system cancer	0.000417	0.00101	CcSEcCtD
Pentamidine—Body temperature increased—Carmustine—lymphatic system cancer	0.000417	0.00101	CcSEcCtD
Pentamidine—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000411	0.000998	CcSEcCtD
Pentamidine—Pancytopenia—Methotrexate—lymphatic system cancer	0.000408	0.000989	CcSEcCtD
Pentamidine—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000404	0.00098	CcSEcCtD
Pentamidine—Neutropenia—Methotrexate—lymphatic system cancer	0.000401	0.000974	CcSEcCtD
Pentamidine—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000401	0.000972	CcSEcCtD
Pentamidine—Abdominal pain—Vincristine—lymphatic system cancer	0.000398	0.000965	CcSEcCtD
Pentamidine—Body temperature increased—Vincristine—lymphatic system cancer	0.000398	0.000965	CcSEcCtD
Pentamidine—Urticaria—Mitoxantrone—lymphatic system cancer	0.000389	0.000944	CcSEcCtD
Pentamidine—Hypersensitivity—Carmustine—lymphatic system cancer	0.000388	0.000942	CcSEcCtD
Pentamidine—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000387	0.00094	CcSEcCtD
Pentamidine—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000387	0.00094	CcSEcCtD
Pentamidine—Vomiting—Bleomycin—lymphatic system cancer	0.000384	0.000931	CcSEcCtD
Pentamidine—Drowsiness—Methotrexate—lymphatic system cancer	0.000383	0.000929	CcSEcCtD
Pentamidine—Rash—Bleomycin—lymphatic system cancer	0.000381	0.000924	CcSEcCtD
Pentamidine—Dermatitis—Bleomycin—lymphatic system cancer	0.00038	0.000923	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000379	0.000921	CcSEcCtD
Pentamidine—Asthenia—Carmustine—lymphatic system cancer	0.000378	0.000917	CcSEcCtD
Pentamidine—Renal failure—Methotrexate—lymphatic system cancer	0.000376	0.000913	CcSEcCtD
Pentamidine—Stomatitis—Methotrexate—lymphatic system cancer	0.000373	0.000905	CcSEcCtD
Pentamidine—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000372	0.000903	CcSEcCtD
Pentamidine—Hypersensitivity—Vincristine—lymphatic system cancer	0.000371	0.000899	CcSEcCtD
Pentamidine—Haematuria—Methotrexate—lymphatic system cancer	0.000365	0.000885	CcSEcCtD
Pentamidine—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000361	0.000876	CcSEcCtD
Pentamidine—Asthenia—Vincristine—lymphatic system cancer	0.000361	0.000876	CcSEcCtD
Pentamidine—Diarrhoea—Carmustine—lymphatic system cancer	0.000361	0.000875	CcSEcCtD
Pentamidine—Nausea—Bleomycin—lymphatic system cancer	0.000359	0.00087	CcSEcCtD
Pentamidine—Asthenia—Mitoxantrone—lymphatic system cancer	0.000352	0.000853	CcSEcCtD
Pentamidine—Dizziness—Carmustine—lymphatic system cancer	0.000349	0.000846	CcSEcCtD
Pentamidine—Diarrhoea—Vincristine—lymphatic system cancer	0.000344	0.000835	CcSEcCtD
Pentamidine—Hepatitis—Methotrexate—lymphatic system cancer	0.000344	0.000834	CcSEcCtD
Pentamidine—Pharyngitis—Methotrexate—lymphatic system cancer	0.000341	0.000827	CcSEcCtD
Pentamidine—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000335	0.000813	CcSEcCtD
Pentamidine—Vomiting—Carmustine—lymphatic system cancer	0.000335	0.000813	CcSEcCtD
Pentamidine—Dizziness—Vincristine—lymphatic system cancer	0.000333	0.000807	CcSEcCtD
Pentamidine—Rash—Carmustine—lymphatic system cancer	0.000332	0.000806	CcSEcCtD
Pentamidine—Dermatitis—Carmustine—lymphatic system cancer	0.000332	0.000805	CcSEcCtD
Pentamidine—Headache—Carmustine—lymphatic system cancer	0.00033	0.000801	CcSEcCtD
Pentamidine—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000325	0.000788	CcSEcCtD
Pentamidine—Vomiting—Vincristine—lymphatic system cancer	0.00032	0.000776	CcSEcCtD
Pentamidine—Rash—Vincristine—lymphatic system cancer	0.000317	0.00077	CcSEcCtD
Pentamidine—Dermatitis—Vincristine—lymphatic system cancer	0.000317	0.000769	CcSEcCtD
Pentamidine—Headache—Vincristine—lymphatic system cancer	0.000315	0.000765	CcSEcCtD
Pentamidine—Nausea—Carmustine—lymphatic system cancer	0.000313	0.00076	CcSEcCtD
Pentamidine—Vomiting—Mitoxantrone—lymphatic system cancer	0.000312	0.000756	CcSEcCtD
Pentamidine—Rash—Mitoxantrone—lymphatic system cancer	0.000309	0.00075	CcSEcCtD
Pentamidine—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000309	0.000749	CcSEcCtD
Pentamidine—Chills—Methotrexate—lymphatic system cancer	0.000308	0.000748	CcSEcCtD
Pentamidine—Headache—Mitoxantrone—lymphatic system cancer	0.000307	0.000745	CcSEcCtD
Pentamidine—Erythema—Methotrexate—lymphatic system cancer	0.000299	0.000726	CcSEcCtD
Pentamidine—Nausea—Vincristine—lymphatic system cancer	0.000299	0.000725	CcSEcCtD
Pentamidine—Dysgeusia—Methotrexate—lymphatic system cancer	0.000293	0.000711	CcSEcCtD
Pentamidine—Nausea—Mitoxantrone—lymphatic system cancer	0.000291	0.000706	CcSEcCtD
Pentamidine—Vision blurred—Methotrexate—lymphatic system cancer	0.000282	0.000684	CcSEcCtD
Pentamidine—Anaemia—Methotrexate—lymphatic system cancer	0.000276	0.000671	CcSEcCtD
Pentamidine—Vertigo—Methotrexate—lymphatic system cancer	0.000269	0.000652	CcSEcCtD
Pentamidine—Leukopenia—Methotrexate—lymphatic system cancer	0.000268	0.00065	CcSEcCtD
Pentamidine—Cough—Methotrexate—lymphatic system cancer	0.000261	0.000633	CcSEcCtD
Pentamidine—Convulsion—Methotrexate—lymphatic system cancer	0.000259	0.000629	CcSEcCtD
Pentamidine—Chest pain—Methotrexate—lymphatic system cancer	0.000255	0.000618	CcSEcCtD
Pentamidine—Myalgia—Methotrexate—lymphatic system cancer	0.000255	0.000618	CcSEcCtD
Pentamidine—Arthralgia—Methotrexate—lymphatic system cancer	0.000255	0.000618	CcSEcCtD
Pentamidine—Discomfort—Methotrexate—lymphatic system cancer	0.000252	0.00061	CcSEcCtD
Pentamidine—Confusional state—Methotrexate—lymphatic system cancer	0.000246	0.000597	CcSEcCtD
Pentamidine—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000244	0.000592	CcSEcCtD
Pentamidine—Infection—Methotrexate—lymphatic system cancer	0.000243	0.000588	CcSEcCtD
Pentamidine—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000239	0.00058	CcSEcCtD
Pentamidine—Anorexia—Methotrexate—lymphatic system cancer	0.000233	0.000565	CcSEcCtD
Pentamidine—Hypotension—Methotrexate—lymphatic system cancer	0.000228	0.000553	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000222	0.00054	CcSEcCtD
Pentamidine—Insomnia—Methotrexate—lymphatic system cancer	0.000221	0.000536	CcSEcCtD
Pentamidine—Paraesthesia—Methotrexate—lymphatic system cancer	0.000219	0.000532	CcSEcCtD
Pentamidine—Dyspnoea—Methotrexate—lymphatic system cancer	0.000218	0.000528	CcSEcCtD
Pentamidine—Somnolence—Methotrexate—lymphatic system cancer	0.000217	0.000527	CcSEcCtD
Pentamidine—Dyspepsia—Methotrexate—lymphatic system cancer	0.000215	0.000521	CcSEcCtD
Pentamidine—Decreased appetite—Methotrexate—lymphatic system cancer	0.000212	0.000515	CcSEcCtD
Pentamidine—Fatigue—Methotrexate—lymphatic system cancer	0.00021	0.000511	CcSEcCtD
Pentamidine—Pain—Methotrexate—lymphatic system cancer	0.000209	0.000506	CcSEcCtD
Pentamidine—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000201	0.000488	CcSEcCtD
Pentamidine—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.0002	0.000484	CcSEcCtD
Pentamidine—Urticaria—Methotrexate—lymphatic system cancer	0.000194	0.000471	CcSEcCtD
Pentamidine—Abdominal pain—Methotrexate—lymphatic system cancer	0.000193	0.000468	CcSEcCtD
Pentamidine—Body temperature increased—Methotrexate—lymphatic system cancer	0.000193	0.000468	CcSEcCtD
Pentamidine—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00018	0.000436	CcSEcCtD
Pentamidine—Asthenia—Methotrexate—lymphatic system cancer	0.000175	0.000425	CcSEcCtD
Pentamidine—Pruritus—Methotrexate—lymphatic system cancer	0.000173	0.000419	CcSEcCtD
Pentamidine—Diarrhoea—Methotrexate—lymphatic system cancer	0.000167	0.000405	CcSEcCtD
Pentamidine—Dizziness—Methotrexate—lymphatic system cancer	0.000161	0.000392	CcSEcCtD
Pentamidine—Vomiting—Methotrexate—lymphatic system cancer	0.000155	0.000377	CcSEcCtD
Pentamidine—Rash—Methotrexate—lymphatic system cancer	0.000154	0.000373	CcSEcCtD
Pentamidine—Dermatitis—Methotrexate—lymphatic system cancer	0.000154	0.000373	CcSEcCtD
Pentamidine—Headache—Methotrexate—lymphatic system cancer	0.000153	0.000371	CcSEcCtD
Pentamidine—Nausea—Methotrexate—lymphatic system cancer	0.000145	0.000352	CcSEcCtD
